Fundraising Fox
/Companies
Sign in

HistoSonics

Ann Arbor, GB · Founded 2009 · Delaware corporation · 447 employees on LinkedIn · 14 known investors

Find your way into HistoSonics

Sign up to see every warm intro you have to HistoSonics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the HistoSonics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

HistoSonics develops histotripsy technology, a non-invasive method that uses focused sound energy to destroy targeted tissue, offered as a medical device for physicians and their patients. The company markets its technology to healthcare providers internationally.

BiotechHardwareHealthtechMedical Devices

Founders & leadership

TDThomas Davison
Thomas DavisonCo-Founder - Chairman CEO2009–2014Thomas Davison holds a Ph.D. in mammalian physiology from Kent State University and has founded or led multiple medical device companies including UltraCision (acquired by Ethicon), Endius (acquired by Zimmer), Sontra Medical (NASDAQ), and HistoSonics, where he served as co-founding Chairman and CEO.
MCM. Christine Gibbons
M. Christine GibbonsCo-Founder / COO2017–2018Christine Gibbons is an executive and director at HistoSonics, a medical device company developing histotripsy technology for non-invasive tissue destruction. She has held roles in venture formation and early-stage company building across multiple technology ventures.
WC
Wen ChenNamed on SEC filing
TT
Tom TefftNamed on SEC filing
MB
Michael BlueNamed on SEC filing
FL
Fred LeeNamed on SEC filing

Board

GBGerry Brunk
Gerry BrunkBoard Of Directors2019–2026Managing Director at Lumira Ventures
JAJim Adox
Jim AdoxBoard MemberExecutive Managing Director at Clarevia Ventures
KK
Kadir KadhiresanBoard director
RM
Robert MorffBoard director
RCRenard Charity
Renard CharityMember Board Of Directors2009–2018Managing Partner at Fletcher Spaght, Inc.
AV
Andrew Von EschenbachBoard director

Investors · 14

Amzak Healthlisted by Amzak HealthNew York
Arboretum Ventureslisted by Arboretum VenturesAnn Arbor · $5M – $15M

How we know: Arboretum Ventures's portfolio page · Not right? Tell us

Early Stage Partners, LPlisted by Early Stage Partners, LPCleveland

How we know: Early Stage Partners, LP's portfolio page · Not right? Tell us

HealthQuest Capitallisted by HealthQuest CapitalRedwood City

How we know: HealthQuest Capital's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us

K5 Globallisted by K5 GlobalSan Francisco · $1M – $3M

How we know: K5 Global's portfolio page · Not right? Tell us

Lumira Ventureslisted by Lumira VenturesToronto · $1M – $10Mvia Gerry Brunk · board

How we know: Lumira Ventures's portfolio page · board seat on SEC Form D · open dataset · 5k.vc investor directory · Not right? Tell us

Michigan Capital Networklisted by Michigan Capital NetworkGrand Rapids
Wellington Managementlisted by Wellington ManagementBoston · $5M – $50M

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

Alpha JWC VenturesreportedSingapore

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

Bezos Expeditionsreported

How we know: the VCSheet dataset · Not right? Tell us

Fletcher Spaght, Inc.inferredBostonvia Renard Charity · board

How we know: board seat on SEC Form D · Not right? Tell us

Hatteras Venture PartnersreportedResearch Triangle · $500K – $4M

How we know: the VCSheet dataset · Not right? Tell us

Johnson & Johnson Innovation – JJDCreportedNew Brunswick

How we know: a partner's Signal profile · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$308.2M disclosed across 9 rounds · 2009–2024

▶$102MraisedAug 2024 · 39 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Fred Lee, Jr.Director
  • Gerry BrunkDirector
  • Wen ChenDirector
  • Michael BlueExecutive Officer, Director
  • V. Kadir KadhiresanDirector
  • Tom TefftDirector
  • Chris DimitropoulosDirector
  • Erica RogersDirector
  • James AdoxDirector
Offering amount
$102M
Amount sold
$102M
First sale
Jul 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$85MraisedDec 2022 · 38 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Wen ChenDirector
  • Tom TefftDirector
  • Michael BlueExecutive Officer, Director
  • Gerry BrunkDirector
  • Jim AdoxDirector
  • Kadir KadhiresanDirector
  • Fred LeeDirector
Offering amount
$85M
Amount sold
$85M
First sale
Dec 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$40.8MraisedJun 2020 · 24 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Gerry BrunkDirector
  • Michael BlueExecutive Officer, Director
  • Richard Eric BoslerExecutive Officer
  • James AdoxDirector
  • Thomas TefftDirector
  • Nikita KulkarniDirector
  • Fred LeeDirector
  • Wen ChenDirector
  • Kadir KadhiresanDirector
Offering amount
$40.8M
Amount sold
$40.8M
First sale
Apr 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$47.4MraisedApr 2019 · 44 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Michael BlueExecutive Officer, Director
  • James AdoxDirector
  • Fred LeeDirector
  • Gerry BrunkDirector
  • Gregory SorensenDirector
  • V. Kadir KadhiresanDirector
  • Tom TefftDirector
Offering amount
$47.4M
Amount sold
$47.4M
First sale
Apr 2019
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7MraisedMar 2019 · 34 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert MorffDirector
  • Fred LeeDirector
  • Jon FreemanExecutive Officer
  • Josh KingExecutive Officer
  • Dan BulverExecutive Officer
  • Andrew Von EschenbachDirector
  • Mike DanielExecutive Officer
  • James AdoxDirector
  • Josh StopekDirector
  • Tom TefftDirector
  • Michael BlueExecutive Officer, Director
  • Akhil TripathiExecutive Officer
  • Linda TuftsDirector
Offering amount
$7M
Amount sold
$7M
Minimum investment
$6.2K
First sale
Apr 2018
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$8.3MraisedFeb 2017 · 13 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Robert MorffDirector
  • Andrew Von EschenbachDirector
  • Fred Lee, Jr.Director
  • Michael BlueExecutive Officer, Director
  • M. Christine GibbonsExecutive Officer
  • Renard CharityDirector
  • James AdoxDirector
Offering amount
$13.3M
Amount sold
$8.3M
First sale
Jan 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.1MraisedAug 2015 · 10 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • M. Christine GibbonsExecutive Officer, Director
  • Thomas DavisonExecutive Officer, Director
  • James AdoxDirector
  • Robert MorffDirector
  • Andrew Von EschenbachDirector
  • Renard CharityDirector
Offering amount
$3M
Amount sold
$2.1M
Minimum investment
$15K
First sale
Jul 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.5MraisedDec 2014 · 8 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Renard CharityDirector
  • Thomas DavisonExecutive Officer, Director
  • Robert MorffDirector
  • Andrew Von EschenbachDirector
  • M. Christine GibbonsExecutive Officer, Director
  • James AdoxDirector
Offering amount
$1.5M
Amount sold
$1.5M
Minimum investment
$18.8K
First sale
Dec 2014
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

2 people who came through HistoSonics went on to found or lead other companies.

Joe AmaralVP Medical/Clinical AffairsFounded LifespanErica RogersDirectorFounded Lightforce

Related companies · 1

MD Anderson Cancer CenterUT MD Anderson is a cancer research and treatment center that provides patient care, conducts research, and offers education in cancer prevention and treatment. It is part of the University of Texas System and operates as a nonprofit medical institution.

Companies working in the same space as HistoSonics.

Frequently asked questions

What does HistoSonics do?
HistoSonics develops histotripsy technology, a non-invasive method that uses focused sound energy to destroy targeted tissue, offered as a medical device for physicians and their patients. The company markets its technology to healthcare providers internationally.
Who are HistoSonics's investors?
HistoSonics's investors include Alpha Wave Global, Amzak Health, Arboretum Ventures, Early Stage Partners, LP, HealthQuest Capital, K5 Global, Lumira Ventures, Michigan Capital Network and 6 more.
How much funding has HistoSonics raised?
HistoSonics has disclosed $308.2M raised across 9 rounds.
Where is HistoSonics headquartered?
HistoSonics is headquartered in Ann Arbor, GB.